United Kingdom · Question · Written question
UIN 145945
Nutrition
Introduced
23 March 2022
Last action
28 March 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
28 March 2022
Summary
To ask the Secretary of State for Health and Social Care, what the Advisory Committee on Borderline Substances' pricing policy for medical nutrition products is; and whether this pricing policy is applied equally to all companies producing those products.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
23 March 2022
Written question
To ask the Secretary of State for Health and Social Care, what the Advisory Committee on Borderline Substances' pricing policy for medical nutrition products is; and whether this pricing policy is applied equally to all companies producing those products.
Source: Commons
28 March 2022
Answer
The Advisory Committee on Borderline Substances pricing policy governs the pricing of all borderline substances listed in Part XV of the Drug Tariff. The terms of the policy are dependent on the type of product application. Type 1 applications relate to n...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-03-23/145945
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1453579
- uk · wq-1453579 · source updated 28 March 2022